A Preview Of Adaptive Biotechnologies's Earnings
Portfolio Pulse from Benzinga Insights
Adaptive Biotechnologies (NASDAQ:ADPT) is set to release its latest quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.33. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $8.44 as of July 31, with a 52-week period decline of 15.47%.
August 04, 2023 | 10:01 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Adaptive Biotechnologies is expected to report an EPS of $-0.33 in its upcoming earnings report. Past earnings have significantly impacted the company's share price.
The upcoming earnings report is highly relevant to Adaptive Biotechnologies' stock price. Past earnings reports have shown a significant impact on the company's share price, indicating that this report could also influence the stock's short-term performance. However, the direction of the impact is uncertain, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100